Expert Review of Vaccines

Papers
(The H4-Index of Expert Review of Vaccines is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Indirect protection from rotavirus vaccines: a systematic review94
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant 79
Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy76
Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks?70
Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States67
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic65
Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response55
Response to letter to the editor on a systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children53
Response to Feemster KA et al. letter to the editor on Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumo52
Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection50
Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis49
The important lessons lurking in the history of meningococcal epidemiology48
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany48
Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays45
Effectiveness of maternal vaccination with quadrivalent inactivated influenza vaccine in pregnant women and their infants in 2019-202043
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review43
Post-marketing surveillance for the safety of the quadrivalent human papillomavirus vaccine: a retrospective real-world study in China41
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era41
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom40
The protective effects of two varicella vaccination strategies: A Bayesian modeling study in two megacities in South China40
Addressing barriers to and strategies for herpes zoster vaccination in immunocompromised patients in Türkiye: an expert consensus40
Personal and contextual determinants of COVID-19 vaccination intention: a vignette study39
Anti-COVID-19 vaccines and rare cases of cerebral venous sinus thrombosis with thrombocytopenia: what about the pragmatic benefit/risk evaluation for still unvaccinated young women36
Microarray patches: scratching the surface of vaccine delivery36
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis36
Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China33
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above33
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy31
Montanide ISA-51: a promising adjuvant in cancer vaccine immunotherapy31
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis31
Off-Label use of vaccines may save lives and money: lessons from the province of Quebec, Canada30
0.10904622077942